nabilone then placebo
The subjects were first on Nabilone, then crossed over to placebo
Loading study record…
Objectives: To determine whether nabilone, a synthetic cannabinoid, alleviates spasticity in people with spinal cord injury (SCI). Methods: Twelve subjects were enrolled in this double-blind, placebo-controlled, crossover study. They received either nabilone or placebo during the first four-week period (0.5mg OD with option to increase to 0.5mg BID), then outcome measures were assessed. After a two-week washout, subjects were crossed-over to the opposite arm. The primary outcome was the Ashworth scale for spasticity in the most involved muscle group, chosen by the subject and clinician. The secondary outcomes included Spasm Frequency Scale, Visual Analog Scale, Wartenberg Pendulum Test, sum of the Ashworth Scale in eight muscle groups of each side of the body, and the Clinician's and Subject's Global Impression of Change .
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2008-02-26
What this record can show
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
Linked local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Interventions
The subjects were first on Nabilone, then crossed over to placebo
the subjects were first on placebo then crossed over to nabilone
Eligibility
primary outcomes
Time frame: 10 weeks
secondary outcomes
Time frame: 10 weeks
Publications
No exact PMID-linked public article is currently readable locally.